Meeting the challenges of haemophilia care and patient support in China and Brazil.
about
Plasma-derived human factor X concentrate for on-demand and perioperative treatment in factor X-deficient patients: pharmacology, pharmacokinetics, efficacy, and safety.The demographics, treatment characteristics and quality of life of adult people with haemophilia in China - results from the HERO study.Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the São Paulo-Toronto Hemophilia Study.Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre.Efficacy of standard prophylaxis versus on-demand treatment with bayer's sucrose-formulated recombinant FVIII (rFVIII-FS) in Chinese children with severe hemophilia A.Nonacog beta pegol in previously treated children with hemophilia B: results from an international open-label phase 3 trial.
P2860
Meeting the challenges of haemophilia care and patient support in China and Brazil.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Meeting the challenges of haemophilia care and patient support in China and Brazil.
@en
type
label
Meeting the challenges of haemophilia care and patient support in China and Brazil.
@en
prefLabel
Meeting the challenges of haemophilia care and patient support in China and Brazil.
@en
P2093
P2860
P1433
P1476
Meeting the challenges of haemophilia care and patient support in China and Brazil.
@en
P2093
Margareth C Ozelo
Márcia A P Matta
Renchi Yang
P2860
P356
10.1111/J.1365-2516.2012.02890.X
P478
18 Suppl 5
P577
2012-07-01T00:00:00Z